Harvard Bioscience
HBIO
74 hedge funds and large institutions have $80.6M invested in Harvard Bioscience in 2014 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 24 reducing their positions, and 12 closing their positions.
1,570% more call options, than puts
Call options by funds: $167K | Put options by funds: $10K
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
0% more funds holding
Funds holding: 74 → 74 (0)
8% less capital invested
Capital invested by funds: $87.4M → $80.6M (-$6.87M)
13% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 24
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$3.47M |
| 2 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$2.58M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.52M |
| 4 |
GPC
Glacier Peak Capital
Bellevue,
Washington
|
+$854K |
| 5 |
Renaissance Technologies
New York
|
+$655K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Penbrook Management
New York
|
-$2.85M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$2.74M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$2.16M |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.34M |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
-$583K |
HBIO Hedge Fund Activity: Q2 2014 in Review
74 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Harvard Bioscience (HBIO) for Q2 2014, worth a combined $80.6M — down 7.9% from $87.4M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new HBIO positions and 12 closed out — a net gain of 1 holder — while 21 added to existing stakes and 24 trimmed.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $3.47M. The largest seller was Penbrook Management, cutting an estimated $2.85M.
- 74 institutional investors held Harvard Bioscience (HBIO) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $80.6M of Harvard Bioscience stock for Q2 2014, down 7.9% quarter-over-quarter.
- 13 funds opened new Harvard Bioscience positions in Q2 2014 and 12 closed out, a net change of +1 holder.
- The largest Harvard Bioscience buyer in Q2 2014 was Bank of Montreal, an estimated $3.47M added.
- The largest Harvard Bioscience seller in Q2 2014 was Penbrook Management, an estimated $2.85M sold.
Based on aggregated 13F filings for Q2 2014.